PG
Patrick Guertin
Principal Investigator
University of Neuchâtel
I'm working on
5 months ago
Control of mosquito, biting fly, tick and mite arthropod ectoparasites and vectors of disease. Developments include pharmacologically active compounds that inhibit biting and blood-feeding, and stand-alone devices for ectoparasite control based on their visual responses.
I'm looking for
6 months ago
Licencing, co-development, pilot-trial engagement.
About
Background in control of insect and tick vectors of disease on man and livestock.
Insect and tick neurophysiology, neuropharmacology, sensory physiology and behaviour.
Biotechnical control of insect, tick and mite vectors of disease.
Preventive measures against ectoparasite infestation at livestock production sites.
Integrated control and management of arthropod ectoparasites such as mosquitoes, biting flies, ticks ad mites.
Partnering listings
Learn more
University of Neuchâtel
Protection against arthropod parasites using purinergic receptor antagonists
This development concerns stopping arthropod ectoparasites such as mosquitoes, biting flies, ticks and mites from attaching and feeding on man, farmed animals and companion animals. These ectoparasites cause considerable...
TechnologyIn developmentUniversity
University of Neuchâtel
Stand-alone 3d visual target for effective fly control
Introducing a 3D visual target designed for efficient fly control. This stand-alone device, with a tubular structure and insecticide-treated surfaces, enhances fly landing rate, improving pest management in various envir...
TechnologyIn developmentUniversity
University of Neuchâtel
Stand-alone mosquito control device using reflected ambient light
Innovative mosquito control device that uses horizontally polarized light to attract egg-laying mosquitoes. It features a no-maintenance, easy-to-produce design suitable for consumer and community-wide use, aiming to red...
TechnologyIn developmentUniversity
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.